Immune Regulation of the Metastatic Process: Implications for Therapy.
Metastatic disease is the major cause of fatalities in cancer patients, but few therapies are designed to target the metastatic process. Cancer cells must perform a number of steps to successfully establish metastatic foci, including local invasion, intravasation, survival, extravasation, and growth in ectopic tissue. Due to the nonrandom distribution of metastasis, it has long been recognized that the tissue microenvironment must be an important determinant of colonization. More recently it has been established in animal models that immune cells regulate the metastatic process, including a dominant role for monocytes and macrophages, and emerging roles for neutrophils and various lymphocyte populations. While most research has focused on the early dissemination process, patients usually present clinically with disseminated, if not macroscopic, disease. Identifying pathways by which immune cells regulate growth and therapeutic resistance within metastatic sites is therefore key to the development of pharmacological agents that will significantly extend patient survival.
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.
A
A
de Mingo Pulido
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States. Electronic address: brian.ruffell@moffitt.org.
B
B
Ruffell
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D059016:Tumor Microenvironment / Q000276:immunology*
D000970:Antineoplastic Agents
Chemotherapy; Immune; Immunotherapy; Leukocyte; Lymphocyte; Macrophage; Metastasis; Monocyte; Neutrophils; Tumor